TSHA
Asset Logo

Taysha Gene Therapies Inc

🇺🇸 NYSE/NASDAQ

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🍃 Esg

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

-22.00%
Annual Growth

4 years average annual growth

🌏

1
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Taysha Gene Therapies Inc is a clinical-stage biotechnology company, which is focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system. The Company’s lead clinical program, TSHA-102, is in development for the treatment of Rett syndrome, a rare neurodevelopmental disorder. The Company is evaluating TSHA-102 in the REVEALPhase I/II adolescent and adult clinical trial, which is a first-in-human, open-label, randomized, dose escalation and dose-expansion, multicenter study evaluating the safety and preliminary efficacy of TSHA-102 in female patients aged 12-years and older with Rett syndrome. It has acquired a worldwide right to a clinical-stage, intrathecally dosed AAV9 gene therapy program, TSHA-120, for the treatment of giant axonal neuropathy (GAN). It received orphan drug designation from the European Commission for TSHA-120 for the treatment of GAN.

📈 Performance

Price History*

-91.57%

1M

1Y

All Time

Graph

Table

* US price history does not take into account stock splits

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$2.01

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in TSHA

0

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

5 days

💵 Average investment amount

$1,637

Last time a customer invested in TSHA

69 days
TSHA investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

👶 Age of investors

18 - 25

26 - 34

35 - 90

🙋 Legal gender of investors

Female

Male

Pearlers who invest in TSHA also invest in...

Fortinet Inc.

FTNT

🙌 Performance (5Yr p.a)

69.71%

📊 Share price

$92.45 USD
Find Out More

🙌 Performance (5Yr p.a)

49.66%

📊 Share price

$137.60 USD

📈 HIGH PRICE GROWTH

🙌 Performance (5Yr p.a)

1070.32%

📊 Share price

$177.33 USD

🙌 Performance (5Yr p.a)

915.57%

📊 Share price

$202.88 USD

🙌 Performance (5Yr p.a)

47.79%

📊 Share price

$135.45 USD

📈 HIGH PRICE GROWTH

Want more shares? Try these...

🙌 Performance (5Yr p.a)

-2.93%

📊 Share price

$4.95 USD
Compare
Add to watchlist